Final Glance: Biotechnology companies
AP - Fri Aug 08, 5:06PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading:
3 Biotech Stocks to End Q2 on a Winning Note - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Fri Aug 08, 2:54PM CDT
The rebound was due to strong earnings reports, product approvals, and acquisitions and licensing deals.
Market Strategy: Play Energy & IT - Analyst Blog
John Blank - Zacks Investment Research - Fri Aug 08, 1:01PM CDT
This deep summer month started us off with investors taking profits, using worry on the Russia-Ukraine-Europe tug of war as an excuse to sell.
Midday Glance: Biotechnology companies
AP - Fri Aug 08, 12:51PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.:
Shares of GILD Up 26.4% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Aug 08, 11:05AM CDT
SmarTrend identified an Uptrend for Gilead Sciences (NASDAQ:GILD) on April 22nd, 2014 at $72.56. In approximately 4 months, Gilead Sciences has returned 26.37% as of today's recent price of $91.69.
Early Glance: Biotechnology companies
AP - Fri Aug 08, 9:51AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
Positive Opinion on the Drug, Acquisition, Orphan Drug Designation, Analysis Results, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Tenet Health
PR Newswire - Fri Aug 08, 8:10AM CDT
Today, Analysts Review released its research reports regarding Gilead Sciences, Inc. (NASDAQ: GILD), Pfizer Inc. (NYSE: PFE), AbbVie Inc. (NYSE: ABBV), Express Scripts Holding Company (NASDAQ: ESRX) and Tenet Healthcare Corp. (NYSE: THC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5592-100free.
Zacks Earnings Trends Highlights: Intel, Micron Technology, Apple, Gilead Sciences and Verizon
PR Newswire - Thu Aug 07, 8:30AM CDT
Zacks Director of Research Sheraz Mian says, "The reduced negative revisions rate at this stage in the reporting cycle is the most notable positive element of this earnings season."
Q3 Earnings Estimates Not Falling As Much - Earnings Trends
Sheraz Mian - Zacks Investment Research - Wed Aug 06, 4:01AM CDT
Q3 Earnings Estimates Not Falling As Much - Earnings Trends
Q3 Earnings Estimates Not Falling As Much - Earnings Outlook
Sheraz Mian - Zacks Investment Research - Wed Aug 06, 4:01AM CDT
Q3 Earnings Estimates Not Falling As Much - Earnings Outlook
'Fast Money' Recap: Is Michael Kors Still in Fashion?
at The Street - Tue Aug 05, 4:00AM CDT
The trading panel looked at Michael Kors' earnings, Microsoft, steel stocks and biotechs.
Gilead Sciences (GILD) Approaches New Upside Target of $93.51
Comtex SmarTrend(R) - Mon Aug 04, 9:02AM CDT
Gilead Sciences (NASDAQ:GILD) has opened bullishly above the pivot of $91.60 today and has reached the first level of resistance at $92.50. Investors may be interested in a cross of the next upside pivot targets of $93.51 and $95.42.
Critical Alerts For Groupon, Gilead Sciences, Ballard Power Systems, GlaxoSmithKline, and Eli Lilly Released By InvestorsObserver
PR Newswire - Mon Aug 04, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for GRPN, GILD, BLDP, GSK, and LLY.